Saturday 17 October 2026
Export SSII’s income statement to Excel — free account
SS Innovations International, Inc.
SSII Healthcare Medical Devices
SS Innovations International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $42.5 million, up 105.7% from fiscal 2024. In the quarter to June 2026, revenue grew 39.4%, EPS fell 669.2%, free cash flow fell 16.6% and total debt rose 109.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
2.55
0.03
−1.16%
Follow SSII
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | — | — | — | 5 | 5 |
P/E ratio |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | — | — | — | — | — | 25.70 | 17.50 |
P/S ratio |
— | — | — | — | — | — | 62.45 | 62.45 | 65.28 | 25.40 |
P/FCF ratio |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | — | — | (13.38) | (2.41) | (4.94) | (0.08) |
Beneish M-Score |
— | — | — | — | — | — | — | 0.72 | (2.09) | (0.72) |
P/Operating CF |
— | — | — | — | — | — | (667.86) | (667.86) | (413.28) | (710.22) |
P/B ratio |
— | — | — | — | — | — | 40.21 | 40.21 | 100.17 | 28.24 |
Price to Tangible BV |
— | — | — | — | — | — | 40.32 | 40.32 | 100.49 | 28.27 |
EV/Sales |
— | — | — | — | — | — | 62.51 | 62.51 | 65.36 | 25.46 |
EV/EBITDA |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | — | — | (80.10) | (80.10) | (142.03) | (58.33) |
EV/FCF |
— | — | — | — | — | — | (65.16) | (65.16) | (132.78) | (48.71) |
Quick Ratio |
0.38 | 1.11 | 0.10 | 0.02 | 0.14 | 1.41 | 0.19 | 1.06 | 0.51 | 0.82 |
Current Ratio |
0.38 | 1.13 | 0.11 | 0.03 | 0.14 | 1.42 | 0.60 | 2.53 | 1.29 | 1.86 |
Net Debt/EBITDA |
0.54 | 0.45 | 0.04 | 0.01 | 0.15 | 0.29 | (0.30) | 0.03 | (0.09) | (0.32) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 37.39% | 20.72% | 18.86% | 15.42% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (1.32) | 0.33 | 0.59 | 0.30 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.32 | 0.29 | 0.56 | 0.73 |
Operating CF/Net income |
0.44 | 0.43 | 0.46 | 0.13 | 0.08 | 0.24 | 0.99 | 0.74 | 0.50 | 1.53 |
Capex/Depreciation |
0.00 | (5.25) | (0.47) | (1.33) | (0.11) | 0.00 | 2.05 | (2.97) | (1.52) | (3.40) |
Interest Coverage |
(20.56) | (37.44) | — | (170.87) | (1,002.64) | — | (35.06) | (22.66) | (19.50) | (7.39) |
| 0.00% | 817.09% | 1,575.55% | 526.47% | 116.41% | 407.94% | 483.05% | (241.96%) | (115.45%) | (46.94%) | |
| 0.00% | (258.71%) | (293.04%) | (2,436.85%) | (499.42%) | (397.67%) | (123.04%) | (103.89%) | (51.83%) | (20.80%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (66.01%) | (78.30%) | (12.64%) |
Return on Tangible Assets |
121.68% | (1,804.70%) | 329.21% | 314.57% | 114.10% | (1,050.46%) | 138.95% | (152.83%) | (166.94%) | (38.31%) |
Average Days of Receivables |
— | — | — | — | — | — | 148.25 | 118.11 | 78.94 | 106.52 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.71% | 18.02% | 12.07% | 8.68% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 417.30% | 336.80% | 118.65% | 54.08% |
Intangible Assets out of Total Assets |
0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 59.35% | 251.69% | 69.46% | 19.13% |
Graham Net Nets |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.01 |
Graham Number |
— | — | — | — | — | — | 0.43 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | — | — | (4.09%) | (4.09%) | (1.42%) | (1.08%) |
Free Cash Flow Yield |
— | — | — | — | — | — | (1.54%) | (1.54%) | (0.75%) | (2.06%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.04 | 0.12 | 0.22 |
Operating CF per Share |
(0.01) | (0.02) | (0.02) | (0.02) | 0.00 | (0.01) | (0.14) | (0.11) | (0.06) | (0.10) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | (0.02) |
Free Cash Flow per Share |
(0.01) | (0.02) | (0.02) | (0.02) | 0.00 | (0.01) | (0.13) | (0.11) | (0.06) | (0.12) |
Cash per Share |
0.01 | 0.02 | 0.00 | 0.00 | 0.01 | 0.01 | 0.04 | 0.05 | 0.04 | 0.05 |
Shareholders Equity per Share |
(0.02) | 0.01 | (0.01) | (0.05) | (0.04) | 0.01 | (0.06) | 0.14 | 0.08 | 0.20 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.02) | 0.01 | (0.01) | (0.05) | (0.04) | 0.01 | (0.06) | 0.14 | 0.08 | 0.20 |
Free Cash Flow |
(0.26) | (0.45) | (0.45) | (0.47) | (0.09) | (0.36) | (5.29) | (15.81) | (10.16) | (22.20) |
Working Capital |
(0.40) | 0.05 | (0.33) | (1.16) | (1.02) | 0.12 | (4.42) | 12.96 | 6.09 | 22.56 |
Capital Expenditures |
(0.04) | 0.00 | (0.01) | (0.05) | 0.00 | — | 0.26 | (0.45) | (0.66) | (3.66) |
Net Current Asset Value |
(0.40) | 0.05 | (0.33) | (1.16) | (1.02) | 0.12 | (4.42) | 9.63 | (1.51) | 12.79 |
EV/EBIT |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | (0.18) | 0.08 | 0.03 | 0.09 |
Price to Operating Income |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
— | 0.24 | 0.55 | 0.45 | 0.98 | 0.92 | 0.33 | 0.22 | 0.08 | 0.12 |
Cash ROIC |
238.91% | (81.47%) | 241.59% | 45.82% | 13.34% | (66.35%) | (225.07%) | (47.49%) | (36.62%) | (37.76%) |
Accounts Receivable Turnover |
— | — | — | — | — | — | 0.00 | 4.71 | 6.49 | 5.04 |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.61 | 6.77 | 7.59 | 6.17 |
Inventory Turnover |
— | — | — | — | — | — | 0.00 | 1.31 | 1.42 | 1.68 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 233.20 | 63.90 | 69.20 | 81.58 |
Days of Inventory on Hand |
— | — | — | — | — | — | 322.46 | 497.40 | 305.44 | 271.50 |
Average Receivables |
— | — | — | — | — | — | — | 1.25 | 3.18 | 8.43 |
Average Payables |
— | 0.03 | 0.01 | 0.08 | 0.14 | 0.13 | 0.37 | 0.76 | 1.61 | 3.72 |
Average Inventory |
— | — | — | — | — | — | — | 3.94 | 8.61 | 13.64 |
Average Assets |
— | 0.40 | 0.33 | 0.14 | 0.23 | 0.37 | 4.55 | 20.10 | 36.95 | 58.31 |
Average Common Equity |
— | (0.13) | (0.06) | (0.64) | (0.97) | (0.36) | (1.16) | 8.63 | 16.59 | 25.84 |
Columns are period end dates